GENE ONLINE|News &
Opinion
Blog

Antibody
COVID-19 COVID-19
FDA Gives Emergency Approval for Lilly’s Anti-Omicron Antibody Treatment
2022-02-14
China Autoimmune
GSK’s Benlysta Bags Approval for Lupus Nephritis Treatment in China
2022-02-14
Asia-Pacific Neurodegenerative Disease
Japan’s Ono Pharmaceutical Expands Collab with Neurimmune to Discover Antibodies for Neurodegenerative Disorders
2022-01-18
Technology COVID-19 Variant
Celltrion’s New Antibody Is Effective against the Omicron Variant
2022-01-06
COVID-19 AstraZeneca
AstraZeneca’s Antibody Becomes the First Pre-exposure COVID-19 Treatment in the US
2021-12-09
Trials & Approvals Cancer
AstraZeneca’s Imfinzi Beats Standard of Care in Advanced Biliary Tract Cancer
2021-10-26
Trials & Approvals Atopic Dermatitis
Kyowa Kirin, Amgen’s Atopic Dermatitis Drug Delivers Strong Results in Phase 2 Trial
2021-10-05
COVID-19 Llama Antibody
New Study Supports Llama Nanobodies As Potential COVID-19 Treatment
2021-09-23
Special
Day 1 ESMO 2021 Roundup: Investigational Immunotherapies Show Promise in Early Cancer Trials
2021-09-18
China Investigational New Drug
Innovent to Send the First-Ever SIRPa Targeting Antibody to Human Trials in China
2021-09-10
Trials & Approvals Aduhelm
AC Immune’s Stock Climbs Following Mixed Phase 2 Trial Results for Alzheimer’s Disease Drug
2021-09-01
China
Another Homegrown Anti-PD-1 Antibody Scores Regulatory Win in China
2021-08-31
COVID-19 Antibody Cocktail
Brii Bio’s COVID-19 Antibody Cocktail Sees Promising Results in Phase 3 ACTIV-2 Trial
2021-08-26
M&A Immuno-oncology
Pfizer Jumps into the CD47 Race With $2.3B Buyout of Trillium
2021-08-24
Trials & Approvals Immunotherapy
Chinese Regulator Accepts BeiGene’s Tislelizumab sBLA for Nasopharyngeal Cancer
2021-08-23
1 2 3 4 … 6
LATEST
The Gene & Cell Therapy Landscape: Recent Approvals and Upcoming Therapeutics of Interest
2024-05-06
Exploring Key Areas of RNA Therapeutics Development: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Mastering Gene & Cell Therapy: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top